Ning Jiang

No ORCID on file · 2 papers in corpus

observational 2023

Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020

Human vaccines & immunotherapeutics ·doi:10.1080/21645515.2023.2283912

Following the approval of Cervarix for the immunization of girls and women in China against high-risk human papillomavirus types 16 and 18, a non-interventional post-authorization safety study was performed. A multi-center prospective cohor…

other 2022

Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma

Nature communications ·doi:10.1038/s41467-022-33982-7

Endometrial cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states. Current models do not adequately reflect oncogenic origin and pathological progression in patients. Here we use single-…